In addition, we showed markedly higher levels of IFN-γ–induced chemokines in patients with active, untreated AOSD compared with RA patients and HCs, and these chemokines correlated with the levels of several disease activity markers and systemic scores. This evidence concerns the gene IFNG and rheumatoid arthritis.